Scientists have demonstrated a method for generating several key types of eye tissue from human stem cells in a way that mirrors whole eye development.
When transplanted to an animal model of corneal blindness, these tissues are shown to repair the front of the eye and restore vision, which scientists say could pave the way for human clinical trials of anterior eye transplantation to restore lost or damaged vision.
A collaborative team comprising researchers from Cardiff University and Osaka University in Japan describe their findings today (embargo: 18:00GMT, 09 March, 2016) in Nature.
The eye is composed of highly specialized tissues that are derived from a variety of cell lineages during development.
Previous studies have demonstrated that particular cell types, such as those that constitute the retina or cornea, can be created in the laboratory from pluripotent stem cells. However, these studies do not represent the complexity of whole eye development.
This latest study reports the generation of multiple cell lineages of the eye, including the lens, cornea, and conjunctiva, using human induced pluripotent stem cells.
The scientists have been able to show that the corneal epithelial cells can be cultivated and transplanted onto the eyes of rabbits with experimentally induced blindness to surgically repair the front of the eye.
Study co-author, Professor Andrew Quantock, said: “This research shows that various types of human stem cells are able to take on the characteristics of the cornea, lens and retina.
“Importantly, it demonstrates that one cell type – the corneal epithelium – could be further grown in the lab and then transplanted on to a rabbit’s eye where it was functional, achieving recovered vision.
“Our work not only holds potential for developing cells for treatment of other areas of the eye, but could set the stage for future human clinical trials of anterior eye transplantation to restore visual function.”
The Latest on: Stem cell transplantation
via Google News
The Latest on: Stem cell transplantation
- What Are Stem Cells? on April 18, 2019 at 8:55 am
[How Stem Cell Cloning Works (Infographic)] Adult stem cells ... Much more research is needed on iPSCs, but scientists hope to use them in transplantation medicine, according to the NIH. Jeanna has ... […]
- Talaris Therapeutics, Inc. Announces $100M Series A Financing to Advance Its Novel, Allogeneic Cell Therapy Through Late-Stage Clinical Development on April 18, 2019 at 6:36 am
She has devoted over 30 years of her career to researching and developing approaches to induce immune tolerance in organ transplant recipients and to enable safer allogeneic stem cell transplant ... […]
- Talaris relaunches in Boston with $100M for organ transplant drug replacement on April 18, 2019 at 4:10 am
The newly retooled company will use the money to develop a stem cell treatment that could permanently replace the anti-rejection drugs people who have received transplants must take to stop their body ... […]
- $100M for Talaris Gives Surgeon a Shot to Reinvent Organ Transplants on April 18, 2019 at 3:02 am
Agnieszka Czechowicz, an assistant professor of pediatrics at Stanford University’s Division of Stem Cell Transplantation and Regenerative Medicine, who isn’t associated with Talaris ... […]
- The Lifesaving Power in Stem Cells on April 18, 2019 at 1:00 am
Stem cell treatments have been in the news lately because some ... cord blood as an insurance policy in case her first child suffered a recurrence. Cord blood transplants can be used to reconstitute a ... […]
- Stem Cell Manufacturing Market 2019 Industry Size, Share, Future Growth, Research Methodology, with Top Major Players by 2023 on April 17, 2019 at 7:07 pm
Rising stem cell related transplants, increasing number of clinical trials for stem cell therapies and growing stem cell research is anticipated to boost the growth of the market during the assessment ... […]
- Stem Cell Procedure Offering Hope Of Breakthrough Cure For Crohn’s Disease on April 17, 2019 at 5:36 pm
Every medication doctors had tried failed. That’s when he volunteered for a stem cell transplant clinical trial. “I was at the end of my rope,” said Miceli. “I had no choice.&rdquo […]
- Stem cell transplant firms Kiadis and CytoSen join forces on April 17, 2019 at 2:38 am
Dutch biotech Kiadis has agreed to acquire US counterpart CytoSen and pool their resources in the emerging field of cell-based cancer immunotherapy. Kiadis has focused its energies to date on the ... […]
- Kuwaiti doctor 'completes' stem cell transplant program in UK on April 13, 2019 at 2:18 pm
LONDON, April 13, (KUNA): Kuwaiti Dr Sondos Al-Shereda completes a two-year training program in cultivation of stem cells at the Leeds Medical Center in the United Kingdom. Al-Shereda is the first ... […]
- Stem cell innovation wins UB's Panasci competition on April 11, 2019 at 3:33 pm
A startup developing a way to use a patient's own stem cells to repair liver damage, instead of doing a transplant, was the winning entry in the University at Buffalo's Henry A. Panasci Jr ... […]
via Bing News